Could CAR-T-cell therapy offer hope to children with cancer?
Elie Dolgin • December 19, 2022
The immunotherapy is beginning to show promise in solid tumours, but researchers want more dedicated research in young people.
Continue reading at Nature Outlook.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.